Depends a lot on what JC says this week I'd say as well as the expenses for the quarter
- Forums
- ASX - By Stock
- AVH
- Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt, page-103
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.68 |
Change
0.150(4.25%) |
Mkt cap ! $257.1M |
Open | High | Low | Value | Volume |
$3.69 | $3.77 | $3.61 | $917.4K | 248.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 587 | $3.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.68 | 1999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 587 | 3.660 |
1 | 500 | 3.620 |
2 | 2138 | 3.600 |
1 | 278 | 3.590 |
2 | 10774 | 3.550 |
Price($) | Vol. | No. |
---|---|---|
3.680 | 1999 | 1 |
3.690 | 1273 | 2 |
3.700 | 24243 | 1 |
3.710 | 8475 | 2 |
3.720 | 351 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online